iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Update

iCoreConnect Inc. (NASDAQ:ICCT) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 46,300 shares, a decrease of 37.3% from the January 31st total of 73,900 shares. Approximately 3.3% of the shares of the company are sold short. Based on an average daily trading volume, of 620,500 shares, the short-interest ratio is presently 0.1 days.

iCoreConnect Stock Performance

Shares of NASDAQ:ICCT traded down $0.41 on Friday, reaching $0.78. The company’s stock had a trading volume of 995,039 shares, compared to its average volume of 1,090,065. The stock has a market capitalization of $1.62 million, a P/E ratio of -0.01 and a beta of 0.87. iCoreConnect has a 52-week low of $0.78 and a 52-week high of $35.80. The stock’s 50-day moving average is $2.31 and its two-hundred day moving average is $5.13. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.11 and a quick ratio of 0.11.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iCoreConnect stock. Magnus Financial Group LLC bought a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 25,010 shares of the company’s stock, valued at approximately $63,000. Magnus Financial Group LLC owned 2.05% of iCoreConnect at the end of the most recent quarter. Institutional investors and hedge funds own 13.42% of the company’s stock.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.